|
US4179338A
(en)
|
1977-09-19 |
1979-12-18 |
Gordon Maurice R |
Microbiological medium suitable for sterilization by ionizing radiation
|
|
JPS6023084B2
(ja)
|
1979-07-11 |
1985-06-05 |
味の素株式会社 |
代用血液
|
|
WO1981001145A1
(en)
|
1979-10-18 |
1981-04-30 |
Univ Illinois |
Hydrolytic enzyme-activatible pro-drugs
|
|
US4640835A
(en)
|
1981-10-30 |
1987-02-03 |
Nippon Chemiphar Company, Ltd. |
Plasminogen activator derivatives
|
|
US4496689A
(en)
|
1983-12-27 |
1985-01-29 |
Miles Laboratories, Inc. |
Covalently attached complex of alpha-1-proteinase inhibitor with a water soluble polymer
|
|
DE3675588D1
(de)
|
1985-06-19 |
1990-12-20 |
Ajinomoto Kk |
Haemoglobin, das an ein poly(alkenylenoxid) gebunden ist.
|
|
WO1987005330A1
(en)
|
1986-03-07 |
1987-09-11 |
Michel Louis Eugene Bergh |
Method for enhancing glycoprotein stability
|
|
US4861719A
(en)
|
1986-04-25 |
1989-08-29 |
Fred Hutchinson Cancer Research Center |
DNA constructs for retrovirus packaging cell lines
|
|
US4791192A
(en)
|
1986-06-26 |
1988-12-13 |
Takeda Chemical Industries, Ltd. |
Chemically modified protein with polyethyleneglycol
|
|
GB8705477D0
(en)
|
1987-03-09 |
1987-04-15 |
Carlton Med Prod |
Drug delivery systems
|
|
EP0307434B2
(en)
|
1987-03-18 |
1998-07-29 |
Scotgen Biopharmaceuticals, Inc. |
Altered antibodies
|
|
US4975278A
(en)
|
1988-02-26 |
1990-12-04 |
Bristol-Myers Company |
Antibody-enzyme conjugates in combination with prodrugs for the delivery of cytotoxic agents to tumor cells
|
|
US5204244A
(en)
|
1987-10-27 |
1993-04-20 |
Oncogen |
Production of chimeric antibodies by homologous recombination
|
|
US5202238A
(en)
|
1987-10-27 |
1993-04-13 |
Oncogen |
Production of chimeric antibodies by homologous recombination
|
|
US5278056A
(en)
|
1988-02-05 |
1994-01-11 |
The Trustees Of Columbia University In The City Of New York |
Retroviral packaging cell lines and process of using same
|
|
US5208020A
(en)
|
1989-10-25 |
1993-05-04 |
Immunogen Inc. |
Cytotoxic agents comprising maytansinoids and their therapeutic use
|
|
US5670488A
(en)
|
1992-12-03 |
1997-09-23 |
Genzyme Corporation |
Adenovirus vector for gene therapy
|
|
DE69303494T2
(de)
|
1992-11-13 |
1997-01-16 |
Idec Pharma Corp |
Therapeutische verwendung von chimerischen und markierten antikörper gegen menschlichen b lymphozyt beschränkter differenzierung antigen für die behandlung von b-zell-lymphoma
|
|
DE69434860T2
(de)
|
1993-02-22 |
2007-03-15 |
The Rockefeller University |
Herstellung von helfer-freien retroviren mit hohem titer mittels transienter transfektion
|
|
FR2712812B1
(fr)
|
1993-11-23 |
1996-02-09 |
Centre Nat Rech Scient |
Composition pour la production de produits thérapeutiques in vivo.
|
|
IL116816A
(en)
|
1995-01-20 |
2003-05-29 |
Rhone Poulenc Rorer Sa |
Cell for the production of a defective recombinant adenovirus or an adeno-associated virus and the various uses thereof
|
|
US5731168A
(en)
|
1995-03-01 |
1998-03-24 |
Genentech, Inc. |
Method for making heteromultimeric polypeptides
|
|
AU690474B2
(en)
|
1995-09-11 |
1998-04-23 |
Kyowa Hakko Kirin Co., Ltd. |
Antibody againts alpha-chain of human interleukin 5 receptor
|
|
US6013516A
(en)
|
1995-10-06 |
2000-01-11 |
The Salk Institute For Biological Studies |
Vector and method of use for nucleic acid delivery to non-dividing cells
|
|
CA2243235C
(en)
|
1996-01-17 |
2010-08-10 |
Imperial College Innovations Limited |
Immunotherapy using cytotoxic t lymphocytes (ctl)
|
|
KR20020011967A
(ko)
|
1999-03-02 |
2002-02-09 |
에드워드 에이. 맥더모트, 주니어 |
ＭＡＧＥ 5, 8, 9 및 11의 ｃＤＮＡ 클로닝 및 이를이용한 암 진단 방법
|
|
AU5076301A
(en)
|
1999-12-06 |
2001-07-09 |
Board Of Trustees Of The University Of Illinois, The |
High affinity tcr proteins and methods
|
|
WO2001041741A1
(en)
*
|
1999-12-13 |
2001-06-14 |
Epimmune Inc. |
Hla class i a2 tumor associated antigen peptides and vaccine compositions
|
|
ATE389668T1
(de)
*
|
2000-07-31 |
2008-04-15 |
Greenpeptide Co Ltd |
Tumorantigen
|
|
WO2002072627A2
(en)
|
2001-03-09 |
2002-09-19 |
Callistogen Ag |
Induction of anti-tumor cytotoxic t-lymphocytes in humans using peptide epitopes found by computer based algorithms for vaccination
|
|
US6833441B2
(en)
|
2001-08-01 |
2004-12-21 |
Abmaxis, Inc. |
Compositions and methods for generating chimeric heteromultimers
|
|
US20050063947A1
(en)
|
2002-03-27 |
2005-03-24 |
Patrick Hwu |
Method for treating cancer in humans
|
|
DE10225139A1
(de)
|
2002-05-29 |
2004-02-26 |
Immatics Biotechnologies Gmbh |
Verfahren zur Identifizierung von immunreaktiven Peptiden
|
|
AU2003276403B2
(en)
|
2002-11-09 |
2010-04-15 |
Adaptimmune Limited |
T cell receptor display
|
|
GB0308731D0
(en)
|
2003-04-15 |
2003-05-21 |
Anticancer Therapeutic Inv Sa |
Method of radiotherapy
|
|
US7807392B1
(en)
|
2003-09-15 |
2010-10-05 |
Celera Corporation |
Lung disease targets and uses thereof
|
|
WO2005076009A2
(en)
|
2004-01-28 |
2005-08-18 |
Immatics Biotechnologies Gmbh |
Method for identifying and quantifying of tumour-associated peptides
|
|
MX2007010349A
(es)
*
|
2005-02-24 |
2008-04-09 |
Cemines Inc |
Composiciones y metodos para clasificar muestras biologicas.
|
|
US9963510B2
(en)
|
2005-04-15 |
2018-05-08 |
Macrogenics, Inc. |
Covalent diabodies and uses thereof
|
|
EP1806358B1
(en)
|
2005-09-05 |
2010-03-17 |
Immatics Biotechnologies GmbH |
Tumor-associated peptides binding promiscuously to human leukocyte antigen (HLA) class II molecules
|
|
CN101287831B
(zh)
|
2005-09-13 |
2013-05-15 |
国立大学法人三重大学 |
T细胞受体和编码该受体的核酸
|
|
WO2008053573A1
(fr)
|
2006-10-30 |
2008-05-08 |
National University Corporation Hokkaido University |
Remède pour néoplasme malin
|
|
BRPI0813626A2
(pt)
|
2007-07-27 |
2014-12-23 |
Immatics Biotechnologies Gmbh |
Epitopos imunogênicos para a imunoterapia
|
|
PE20090993A1
(es)
|
2007-08-29 |
2009-07-08 |
Sanofi Aventis |
Anticuerpos anti-cxcr5 humanizados y derivados de los mismos
|
|
EP3415529B1
(en)
|
2007-09-26 |
2020-11-04 |
Chugai Seiyaku Kabushiki Kaisha |
Modified antibody constant region
|
|
EP2288700B1
(en)
|
2008-05-09 |
2017-02-08 |
Agency for Science, Technology And Research |
Hbv epitope reactive exogenous t cell receptor (tcr) and uses thereof
|
|
RS53872B2
(sr)
|
2008-05-14 |
2018-06-29 |
Immatics Biotechnologies Gmbh |
Novi i snažni mhc peptidi klase ii izvedeni iz survivina i neurokana
|
|
TW201008574A
(en)
*
|
2008-08-19 |
2010-03-01 |
Oncotherapy Science Inc |
INHBB epitope peptides and vaccines containing the same
|
|
US20110318380A1
(en)
|
2008-10-01 |
2011-12-29 |
Dako Denmark A/S |
MHC Multimers in Cancer Vaccines and Immune Monitoring
|
|
US9840695B2
(en)
|
2009-04-28 |
2017-12-12 |
Agriculture Victoria Services Pty Ltd |
Plant technology
|
|
EP2258719A1
(en)
|
2009-05-19 |
2010-12-08 |
Max-Delbrück-Centrum für Molekulare Medizin (MDC) |
Multiple target T cell receptor
|
|
GB0917094D0
(en)
|
2009-09-29 |
2009-11-11 |
Ucl Biomedica Plc |
T-cell receptor
|
|
EP2486049A1
(en)
|
2009-10-06 |
2012-08-15 |
The Board Of Trustees Of The UniversityOf Illinois |
Human single-chain t cell receptors
|
|
US20130011496A1
(en)
*
|
2009-11-25 |
2013-01-10 |
Ludwig Institute For Cancer Research Ltd. |
Cancer testis antigens as biomarkers in non-small cell lung cancer
|
|
GB201004551D0
(en)
*
|
2010-03-19 |
2010-05-05 |
Immatics Biotechnologies Gmbh |
NOvel immunotherapy against several tumors including gastrointestinal and gastric cancer
|
|
GB201006360D0
(en)
|
2010-04-16 |
2010-06-02 |
Immatics Biotechnologies Gmbh |
Method for differentially quantifying naturally processed HLA-restricted peptides for cancer, autoimmune and infectious diseases immunotherapy development
|
|
WO2011146473A1
(en)
|
2010-05-17 |
2011-11-24 |
Duke University |
Methods of treatment using ex vivo expansion of cord blood t cells
|
|
CN101870725B
(zh)
*
|
2010-06-29 |
2012-06-27 |
郑州大学 |
Mage-4抗肿瘤ctl表位肽及其应用
|
|
AU2011304728A1
(en)
|
2010-09-20 |
2013-03-14 |
Biontech Ag |
Antigen-specific T cell receptors and T cell epitopes
|
|
TWI838039B
(zh)
|
2011-03-28 |
2024-04-01 |
法商賽諾菲公司 |
具有交叉結合區定向之雙重可變區類抗體結合蛋白
|
|
US20130078250A1
(en)
|
2011-08-23 |
2013-03-28 |
Oliver Ast |
Bispecific t cell activating antigen binding molecules
|
|
US20140322344A1
(en)
*
|
2011-08-31 |
2014-10-30 |
National University Corporation Tokyo Medical And Dental University |
Vaccine preparation for cancer treatment
|
|
WO2013057596A1
(en)
|
2011-10-21 |
2013-04-25 |
Atena Srl |
Anatomic cushion accumulator for thermal treatment with heat or cold
|
|
EP2660250B1
(en)
|
2012-05-02 |
2018-11-14 |
Deutsches Rheuma-Forschungszentrum Berlin |
Tcr transgenic mouse model for immune disease
|
|
EP2877489A4
(en)
|
2012-07-27 |
2016-04-13 |
Univ Illinois |
MANIPULATION OF T-CELL RECEPTORS
|
|
DK2895509T3
(da)
|
2012-09-14 |
2020-03-09 |
Us Health |
T-cellereceptorer, som genkender mhc-klasse ii begrænset mage-a3
|
|
JOP20200236A1
(ar)
|
2012-09-21 |
2017-06-16 |
Regeneron Pharma |
الأجسام المضادة لمضاد cd3 وجزيئات ربط الأنتيجين ثنائية التحديد التي تربط cd3 وcd20 واستخداماتها
|
|
GB2508414A
(en)
|
2012-11-30 |
2014-06-04 |
Max Delbrueck Centrum |
Tumour specific T cell receptors (TCRs)
|
|
CN111925437A
(zh)
|
2013-03-14 |
2020-11-13 |
宏观基因有限公司 |
与表达激活受体的免疫效应细胞具有免疫反应性的双特异性分子
|
|
MX357011B
(es)
|
2013-03-15 |
2018-06-22 |
Amgen Inc |
Anticuerpos biespecificos heterodimericos.
|
|
EP2975942B1
(en)
|
2013-03-21 |
2018-08-08 |
Sangamo Therapeutics, Inc. |
Targeted disruption of t cell receptor genes using engineered zinc finger protein nucleases
|
|
AU2014301777B2
(en)
|
2013-06-26 |
2017-03-30 |
Xlifesc, Ltd. |
High-stability T-cell receptor and preparation method and application thereof
|
|
TWI777194B
(zh)
|
2013-08-05 |
2022-09-11 |
德商伊瑪提克斯生物科技有限公司 |
新穎肽類，細胞及其用於治療多種腫瘤的用途，其製造方法及包含其等之醫藥組成物（一）
|
|
GB201319446D0
(en)
|
2013-11-04 |
2013-12-18 |
Immatics Biotechnologies Gmbh |
Personalized immunotherapy against several neuronal and brain tumors
|
|
JP6164759B2
(ja)
|
2013-11-21 |
2017-07-19 |
Ｒｅｐｅｒｔｏｉｒｅ Ｇｅｎｅｓｉｓ株式会社 |
Ｔ細胞受容体およびｂ細胞受容体レパトアの解析システムならびにその治療および診断への利用
|
|
MX379030B
(es)
|
2013-12-17 |
2025-03-10 |
Genentech Inc |
Anticuerpos anti-cd3 y metodos de uso
|
|
US10202640B2
(en)
|
2014-05-07 |
2019-02-12 |
The Board Of Trustees Of The Leland Stanford Junior University |
Single cell analysis of T cells using high-throughput multiplex amplification and deep sequencing
|
|
GB201408255D0
(en)
|
2014-05-09 |
2014-06-25 |
Immatics Biotechnologies Gmbh |
Novel immunotherapy against several tumours of the blood, such as acute myeloid leukemia (AML)
|
|
WO2015172843A1
(en)
*
|
2014-05-16 |
2015-11-19 |
Biontech Diagnostics Gmbh |
Methods and kits for the diagnosis of cancer
|
|
EP2985294A1
(en)
|
2014-08-14 |
2016-02-17 |
Deutsches Krebsforschungszentrum |
Recombinant antibody molecule and its use for target cell restricted T cell activation
|
|
US10973894B2
(en)
*
|
2014-10-02 |
2021-04-13 |
The United States Of America, As Represented By The Secretary, Department Of Health And Human |
Methods of isolating T cells having antigenic specificity for a cancer-specific mutation
|
|
EP3215164A1
(en)
|
2014-11-03 |
2017-09-13 |
Immures S.r.l. |
T cell receptors
|
|
GB201423361D0
(en)
|
2014-12-30 |
2015-02-11 |
Immatics Biotechnologies Gmbh |
Method for the absolute Quantification of naturally processed HLA-Restricted cancer peptides
|
|
EP3812398A3
(en)
|
2015-01-23 |
2021-07-21 |
Sanofi |
Anti-cd3 antibodies, anti-cd123 antibodies and bispecific antibodies specifically binding to cd3 and/or cd123
|
|
EP3067366A1
(en)
|
2015-03-13 |
2016-09-14 |
Max-Delbrück-Centrum Für Molekulare Medizin |
Combined T cell receptor gene therapy of cancer against MHC I and MHC II-restricted epitopes of the tumor antigen NY-ESO-1
|
|
GB201505305D0
(en)
|
2015-03-27 |
2015-05-13 |
Immatics Biotechnologies Gmbh |
Novel Peptides and combination of peptides for use in immunotherapy against various tumors
|
|
GB201506642D0
(en)
|
2015-04-20 |
2015-06-03 |
Ucl Business Plc |
T cell receptor
|
|
BR112017024757A2
(pt)
|
2015-05-18 |
2018-11-13 |
TCR2 Therapeutics Inc. |
composições e métodos para reprogramação de tcr utilizando proteínas de fusão
|
|
EP3095792A1
(en)
|
2015-05-19 |
2016-11-23 |
Klinikum rechts der Isar der Technischen Universität München |
T cell receptor with specificity for myeloperoxidase peptide and uses thereof
|
|
CN105219714A
(zh)
*
|
2015-10-20 |
2016-01-06 |
上海隆耀生物科技有限公司 |
一种用于激活肺癌特异性免疫反应的试剂盒
|
|
CN105219719A
(zh)
*
|
2015-10-20 |
2016-01-06 |
上海隆耀生物科技有限公司 |
一种用于激活卵巢癌特异性免疫反应的试剂盒
|
|
CN116059316A
(zh)
|
2015-10-23 |
2023-05-05 |
优瑞科生物技术公司 |
抗体/t细胞受体嵌合构建体及其用途
|
|
GB201522592D0
(en)
|
2015-12-22 |
2016-02-03 |
Immunocore Ltd |
T cell receptors
|
|
GB201604458D0
(en)
|
2016-03-16 |
2016-04-27 |
Immatics Biotechnologies Gmbh |
Peptides and combination of peptides for use in immunotherapy against cancers
|
|
DK3430030T5
(da)
*
|
2016-03-16 |
2024-09-23 |
Immatics Biotechnologies Gmbh |
Transficerede t-celler og t-cellereceptorer til anvendelse i immunoterapi mod cancer
|
|
GB201604492D0
(en)
|
2016-03-16 |
2016-04-27 |
Immatics Biotechnologies Gmbh |
Transfected t-cells and t-cell receptors for use in immunotherapy against cancers
|
|
EP3443001B1
(en)
|
2016-04-11 |
2025-04-30 |
Obsidian Therapeutics, Inc. |
REGULATED BIOCIRCUIT SYSTEMS
|
|
WO2018026953A1
(en)
|
2016-08-02 |
2018-02-08 |
TCR2 Therapeutics Inc. |
Compositions and methods for tcr reprogramming using fusion proteins
|
|
JP7012364B2
(ja)
|
2016-08-05 |
2022-02-14 |
国立大学法人東北大学 |
Ｔ細胞受容体の認識機構を用いたがん又は感染症の治療及び診断
|
|
GB201617714D0
(en)
|
2016-10-19 |
2016-11-30 |
Ucl Business Plc |
T Cell receptor
|
|
GB201617716D0
(en)
|
2016-10-19 |
2016-11-30 |
Ucl Business Plc |
Cell
|
|
DE102016121899A1
(de)
|
2016-11-15 |
2018-05-17 |
Immatics Biotechnologies Gmbh |
Verfahren zur Herstellung von elektrokompetenten Hefezellen und Verfahren zur Verwendung dieser Zellen
|
|
DE102016123893A1
(de)
|
2016-12-08 |
2018-06-14 |
Immatics Biotechnologies Gmbh |
T-Zellrezeptoren mit verbesserter Bindung
|
|
BR112019028280A2
(pt)
|
2017-07-04 |
2020-07-14 |
Curevac Ag |
moléculas de ácido nucleico
|
|
PT3428194T
(pt)
|
2017-07-14 |
2021-11-18 |
Immatics Biotechnologies Gmbh |
Molécula de polipéptido com especificidade dupla melhorada
|
|
AU2018318303A1
(en)
|
2017-08-18 |
2020-04-09 |
Gritstone Bio, Inc. |
Antigen-binding proteins targeting shared antigens
|
|
EP3679065A4
(en)
|
2017-09-06 |
2021-05-19 |
California Institute of Technology |
SIGNALING AND ANTIGEN-PRESENTING BIFUNCTIONAL RECEPTORS (SABR)
|
|
EP3707248A4
(en)
|
2017-11-10 |
2021-08-18 |
Chineo Medical Technology Co., Ltd. |
MODIFIED IMMUNE CELLS AND THEIR USES
|
|
DE102017127984B4
(de)
|
2017-11-27 |
2019-12-05 |
Immatics US, Inc. |
Verfahren für die Vermehrung und Aktivierung von γδ-T-Zellen
|
|
TWI837109B
(zh)
|
2017-12-28 |
2024-04-01 |
美商磨石生物公司 |
靶向共有抗原之抗原結合蛋白
|
|
DE102018100967B4
(de)
|
2018-01-17 |
2019-08-14 |
Immatics US, Inc. |
Verfahren zur feststellung der wirksamkeit von viralen vektoren
|
|
EP3747456A4
(en)
|
2018-01-31 |
2021-12-01 |
Tohoku University |
PROCESS FOR REGULATING THE EXPRESSION OF THE SPECIFIC MHC OF AN ANTIGEN
|
|
JP7470640B2
(ja)
|
2018-02-09 |
2024-04-18 |
イマティクス ユーエス，アイエヌシー． |
Ｔ細胞を製造する方法
|
|
DE102018108612A1
(de)
|
2018-03-21 |
2019-09-26 |
Immatics US, Inc. |
Verfahren zur erhöhung der persistenz von adoptiv infundierten t-zellen
|
|
DK3773689T5
(da)
|
2018-04-11 |
2024-08-19 |
Enterome S A |
Antigene peptider til forebyggelse og behandling af kræft
|
|
US20210363216A1
(en)
|
2018-05-14 |
2021-11-25 |
Immunocore Limited |
Bifunctional binding polypeptides
|
|
JP2021526365A
(ja)
|
2018-05-18 |
2021-10-07 |
チルドレンズ ナショナル メディカル センターＣｈｉｌｄｒｅｎ’Ｓ Ｎａｔｉｏｎａｌ Ｍｅｄｉｃａｌ Ｃｅｎｔｅｒ |
改善された標的化ｔ細胞療法
|
|
TW202000907A
(zh)
|
2018-05-23 |
2020-01-01 |
美商葛利史東腫瘤科技公司 |
共有抗原
|
|
AU2019283639A1
(en)
|
2018-06-04 |
2021-01-07 |
Apo-T B.V. |
Methods and means for attracting immune effector cells to tumor cells
|
|
GB201819540D0
(en)
|
2018-11-30 |
2019-01-16 |
Adaptimmune Ltd |
T cell modification
|
|
HUE065436T2
(hu)
|
2019-01-17 |
2024-06-28 |
Immunocore Ltd |
Kiszerelések
|
|
GB201901306D0
(en)
|
2019-01-30 |
2019-03-20 |
Immunocore Ltd |
Multi-domain binding molecules
|
|
MX2021013588A
(es)
|
2019-05-08 |
2022-02-11 |
Medigene Immunotherapies Gmbh |
Células t genomodificadas.
|
|
CN118994397A
(zh)
|
2019-05-21 |
2024-11-22 |
诺华股份有限公司 |
针对bcma的三特异性结合分子及其用途
|
|
CN118994364A
(zh)
|
2019-06-18 |
2024-11-22 |
里珍纳龙药品有限公司 |
Mage-a4 t细胞受体及其使用方法
|
|
GB201911286D0
(en)
|
2019-08-07 |
2019-09-18 |
Ucl Business Plc |
Method
|
|
WO2021073624A1
(zh)
|
2019-10-17 |
2021-04-22 |
北京门罗生物科技有限公司 |
用于免疫治疗的嵌合抗原受体、制备方法及其应用
|
|
CN116096651A
(zh)
|
2020-06-04 |
2023-05-09 |
安全密封系统公司 |
自密封容器
|
|
BR112023022975A2
(pt)
|
2021-05-05 |
2024-01-23 |
Immatics Biotechnologies Gmbh |
Polipeptídeos de ligação ao antígeno bma031 melhorados
|